These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 361207)

  • 1. Combined cytotoxic and progestogen therapy for advanced breast cancer.
    Rubens RD; Begent RH; Knight RK; Sexton SA; Hayward JL
    Cancer; 1978 Oct; 42(4):1680-6. PubMed ID: 361207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adriamycin versus methotrexate in five-drug combination chemotherapy for advanced breast cancer: a randomized trial.
    Muss HB; White DR; Richards F; Cooper MR; Stuart JJ; Jackson DV; Rhyne L; Spurr CL
    Cancer; 1978 Nov; 42(5):2141-8. PubMed ID: 363253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose chemotherapy of metastatic breast cancer with cyclophosphamide, adriamycin, methotrexate, 5-fluorouracil (CAMF) versus sequential cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and adriamycin.
    Creech RH; Catalano RB; Harris DT; Engstrom PF; Grotzinger PJ
    Cancer; 1979 Jan; 43(1):51-9. PubMed ID: 367574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of advanced breast cancer: a randomized trial of vincristine, Adriamycin, and cyclophosphamide (VAC) versus cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP).
    Carmo-Pereira J; Costa FO; Henriques E
    Cancer; 1981 Oct; 48(7):1517-21. PubMed ID: 7026020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival.
    Manni A; Trujillo JE; Pearson OH
    Cancer Treat Rep; 1980 Jan; 64(1):111-6. PubMed ID: 6155207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adriamycin plus vincristine compared to and combined with cyclophosphamide, methotrexate, and 5-fluorouracil for advanced breast cancer.
    De Lena M; Brambilla C; Morabito A; Bonadonna G
    Cancer; 1975 Apr; 35(4):1108-15. PubMed ID: 1116104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy for advanced breast cancer: two regimens containing adriamycin.
    Kennealey GT; Boston B; Mitchell MS; Knobf MK; Bobrow SN; Pezzimenti JF; Lawrence R; Bertino JR
    Cancer; 1978 Jul; 42(1):27-33. PubMed ID: 667798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy for advanced breast cancer utilizing vincristine, adriamycin, and cyclophosphamide (VAC).
    Rainey JM; Jones SE; Salmon SE
    Cancer; 1979 Jan; 43(1):66-71. PubMed ID: 761176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclical combination chemotherapy in advanced breast cancer.
    Edelstyn GA; Macrae KD
    Br J Cancer; 1973 Nov; 28(5):459-61. PubMed ID: 4758373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of rotating chemotherapy in advanced breast cancer. An Eastern Cooperative Oncology Group Trial.
    Tormey D; Gelman R; Falkson G
    Am J Clin Oncol; 1983 Feb; 6(1):1-18. PubMed ID: 6340458
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy of advanced breast cancer--actual results ].
    Matthes ML; Lenk H; Gürtler R; Tanneberger S
    Arch Geschwulstforsch; 1982 May; 52(3):241-6. PubMed ID: 6812538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
    Mouridsen HT; Palshof T
    Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
    [No Abstract]   [Full Text] [Related]  

  • 13. [Metastatic breast cancer: controlled trial of chemotherapy with and without hormones].
    Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Magdelenat H; Asselain B; Pouillart P
    Bull Cancer; 1984; 71(5):432-41. PubMed ID: 6395920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-drug vs combination cytotoxic chemotherapy in advanced breast cancer: a randomized study.
    Carmo-Pereira J; Costa FO; Henriques E
    Eur J Cancer (1965); 1980 Dec; 16(12):1621-5. PubMed ID: 7014228
    [No Abstract]   [Full Text] [Related]  

  • 15. [Five-drug therapy in addition to hormonal treatment in advance breast cancer metastatic to the lung (author's transl)].
    Matthiessen W; Pochhammer KF
    Prax Pneumol; 1976 Aug; 30(8):479-8. PubMed ID: 959156
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
    Spittle MF; Bates TD; Kitchen G; Nicol NT; Wheeler T; Edelstyn G; MacRae KD; Ostrowski MJ
    Clin Oncol; 1980 Jun; 6(2):153-7. PubMed ID: 7408282
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy of metastatic breast cancer: a randomized trial comparing the use of adriamycin to that of Vinblastine.
    Bezwoda WR; de Moor NG; Derman D; Lange M; Saner R; Dando R
    Cancer; 1979 Aug; 44(2):392-7. PubMed ID: 383254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levamisole: as adjuvant to cyclic chemotherapy in breast cancer.
    Stephens EJ; Wood HF; Mason B
    Recent Results Cancer Res; 1978; 68():139-45. PubMed ID: 379932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy of breast cancer.
    Cooper RG; Holland JF; Glidewell O
    Cancer; 1979 Sep; 44(3):793-8. PubMed ID: 476594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of levamisole immunotherapy and polychemotherapy in advanced breast cancer.
    Klefström P
    Cancer Treat Rep; 1980 Jan; 64(1):65-72. PubMed ID: 6991105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.